Stock Analysis

UK Value Picks 3 Stocks Priced Below Estimated Worth

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid weak trade data from China, impacting companies heavily reliant on global demand. In such an environment, identifying undervalued stocks becomes crucial as investors seek opportunities where market prices may not fully reflect a company's intrinsic worth.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

NameCurrent PriceFair Value (Est)Discount (Est)
PageGroup (LSE:PAGE)£2.27£4.4448.9%
LSL Property Services (LSE:LSL)£2.80£5.5849.8%
Likewise Group (AIM:LIKE)£0.28£0.5346.8%
Kromek Group (AIM:KMK)£0.0485£0.09046.2%
Hollywood Bowl Group (LSE:BOWL)£2.495£4.8248.2%
Gym Group (LSE:GYM)£1.478£2.9049.1%
Gooch & Housego (AIM:GHH)£5.50£10.8249.1%
Burberry Group (LSE:BRBY)£11.05£21.0947.6%
AstraZeneca (LSE:AZN)£117.94£223.3947.2%
ACG Metals (LSE:ACG)£9.20£17.3246.9%

Click here to see the full list of 51 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

ACG Metals (LSE:ACG)

Overview: ACG Metals Limited focuses on copper production in Europe and has a market cap of £199.26 million.

Operations: The company's revenue is primarily derived from its mining segment, which generated $57.75 million.

Estimated Discount To Fair Value: 46.9%

ACG Metals is trading at £9.2, significantly below its estimated fair value of £17.32, indicating potential undervaluation based on cash flows. The company forecasts robust revenue growth of 28.4% annually, surpassing the UK market average and expects to become profitable within three years with a high return on equity projected at 29%. Despite recent production challenges, ACG upgraded its annual production guidance due to operational improvements and strategic leadership changes enhancing future prospects.

LSE:ACG Discounted Cash Flow as at Sep 2025
LSE:ACG Discounted Cash Flow as at Sep 2025

Dr. Martens (LSE:DOCS)

Overview: Dr. Martens plc is involved in the design, development, procurement, marketing, sale, and distribution of footwear and has a market cap of approximately £889.09 million.

Operations: The company's revenue is primarily generated from its footwear segment, amounting to £787.60 million.

Estimated Discount To Fair Value: 17.5%

Dr. Martens is trading at £0.92, below its estimated fair value of £1.11, suggesting potential undervaluation based on cash flows. The company's earnings are forecast to grow significantly at 46% annually, outpacing the UK market average. However, profit margins have declined from last year and the dividend yield of 2.77% is not well covered by earnings, raising sustainability concerns despite expected revenue growth surpassing the market's rate slightly at 4.2%.

LSE:DOCS Discounted Cash Flow as at Sep 2025
LSE:DOCS Discounted Cash Flow as at Sep 2025

Gym Group (LSE:GYM)

Overview: The Gym Group plc operates a network of gym facilities under the Gym Group brand name in the United Kingdom, with a market cap of £264.14 million.

Operations: The company's revenue is primarily derived from the provision of high-quality health and fitness facilities, amounting to £235.20 million.

Estimated Discount To Fair Value: 49.1%

The Gym Group is trading at £1.48, significantly below its estimated fair value of £2.9, indicating potential undervaluation based on cash flows. Earnings are forecast to grow at 23.6% annually, faster than the UK market average of 13.8%. Recent earnings showed a strong increase in net income to £3.3 million for H1 2025 from £0.2 million last year, despite revenue growth being slower than desired at 8%.

LSE:GYM Discounted Cash Flow as at Sep 2025
LSE:GYM Discounted Cash Flow as at Sep 2025

Summing It All Up

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com